chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since my booster in Nov my hair has been falling out; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Nov2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete but manufacturer unknown), for Covid-19 immunization. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "Since my booster in Nov my hair has been falling out".  Additional information: Customer Verbatim: Since my booster in Nov my hair has been falling out. I have not had a Covid infection. I've just read online hair loss is occurring to women nationwide as a result of the Vaccines. What is the recommended cure to stop it? I will see a Dermatologist in a week and want to ensure she is up to speed on the recommended fix. Thank you.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
In May 2021 i developed a buzzing noise in my ears that has not gone away.
Redness, swelling, and warmth within a 2 inch diameter circle at the site of injection. Significant pain at and around the site of injection. Began about 18 hours after the injection. That is similar, but higher in intensity, that the response I experienced after my first COVID vaccination. In addition, I also have significant pain and swelling in several axillary lymph nodes on the same side the vaccine was given. Pain is rated 6 out of 10 despite taking Ibuprofen 600mg q4 hours. Pain and swelling in the lymph nodes began about 36 hours after the 2nd vaccination. It has not yet resolved.
Headache, NauseaVomiting, injection site pain, fatigue, loss of appetite Narrative:
rash on face, 1wk p/vax lasting for 30 days vomiting, gen aches & pains for 5 days p/vax;
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 1:55 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Nov-2021 at 1:55 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was unknown if the patient had allergies to food, medications or other products.  It was unknown if the patient was tested positive for COVID-19 or not.  No concomitant medications were reported.  The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion and stored in a super cold Freezer. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. On 19-Nov-2021, the vial moved from freezer to refrigerator, the day when Moderna Covid-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator or maintained at room temperature. The vials were not punctured and temperature excursion was not reported previously.  No vaccine state changes were noticed. The vaccine was never refrozen.  No treatment medications were reported.
This spontaneous report as received from a consumer refers to her son a male patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL (route and lot number not provided) dose 1. On an unknown date the patient got sick. Action taken, outcome and relatedness were not provided. Additional information is not expected.
37yoF presenting 8 days s/p left deltoid administration of her first dose of Moderna COVID vaccine with localized urticarial skin reaction about the injection site (1.5cm in diameter) with secondary site of urticarial skin eruption over the lateral arm approximately 10cm inferior to this which is approximately 5cm x 3cm. Denies any other symptoms associated with vaccine administration except localized arm soreness. No fevers, chills, night sweats. No prior diagnosed COVID infections. Not recently ill. Seasonal allergies historically, but no vaccine adverse effects. No anaphylactoid symptoms. No headaches, myalgias. Treatment with antihistamines and topical corticosteroids prescribed.
Information has been received from a registered nurse concerning multiple unspecified patients of unknown age and gender. The patient's concurrent conditions, medical histories and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses improperly stored PROQUAD (lot # M002055 with expiration date 11-JUL-2017, lot # M006104 with expiration date 01-AUG-2017; dose and route were unknown). The vaccines were exposed under temperature of 40.3 degrees Fahrenheit for 9 hours and 52 minutes. There were not previous temperature excursions. Data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Arm was sore after injection and became increasingly red, hot and itchy up to the size of the palm of my hand by 8 days after injection, before resolving by 14 days.  Called physician because of concern for cellulitis, but was unable to be seen that day.  In the meantime, I researched Moderna rash and felt that was what I was experiencing.  I had an atypical "cold" the last week of January 2019 and never sure if that was a mild case of Covid-19.  My food allergies result in hives and this was more extensive.  Second shot of Moderna received on 2/17/20 in right arm with no reaction, other than sore arm.
pt recvd vax 6APR95 & on the day of vax pt started Augmentin for suspected infect;mom called 8APR to report pt had small local rxn(red @ site);also had a stomachache ache(felt to be caused by Augmentin);10APR pt had small nodule @ inj site
I got up with a headache, chest was extremely congested, took some medication and went back to sleep. Both of my arms hurt from the shots but that was to be expected. When I woke up later my head was still hurting and my chest was still congested but the CORICIDIN D had helped break up some of the congestion. I went back to sleep to see if my head would stop hurting. It felt like I had the flu. I woke up on the second day after the vaccines I got up in the morning still had the headache and congestion but I could actually move around and do things around my home.
Patient experience loss of consciousness, diaphoresis, and urinary incontinence within approximately 10 minutes of receiving vaccine. This resolved within minutes of drinking juice and eating snacks.
powder reconstituted with unapproved diluent; may have received powder reconstituted with unapproved diluent; This case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported finding extra Shingrix diluents, thought a patient might have received a powder vial reconstituted with an unapproved diluent, which led to  wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter did not consented to follow up.
Had a sore arm, fever (99F), body ache and a swelling in the arm pit. Swelling in the armpit still exists
her right arm, where she receive the injection, was sore.; she had "an echo in the right ear and difficulty hearing.; she had "an echo in the right ear and difficulty hearing.; Weirdness around the neck area on the right side, numbness of some sort.; Weirdness around the neck area on the right side, numbness of some sort; This is a spontaneous report from a contactable consumer (patient). A female patient received bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: Not provided) via an unspecified route of administration in right arm on 24Jan2021 as first dose, single for COVID-19 immunization. Patient's medical history and concomitant medication were not reported. On an unspecified date in 2021, on the first day her right arm, where she received the injection, was sore. The next day she woke up and had an echo in the right ear and difficulty hearing. Patient had to see someone that it was so difficult to hear. Patient experienced weirdness around the neck area on the right side, numbness of some sort. It felt full, but it did not feel like water in the ear. Patient did not have this issue before. It had gotten better but it was still there and bothering. Patient wants to know if this was a commonly reported side effect. Patient was inquiring about the efficacy of the Pfizer COVID-19 vaccine after the first dose and wanted to know if she should receive the second dose of the vaccine later than the recommended 3 weeks, which was scheduled for next week, since she experienced this uncommon side effect and was still experiencing residual symptoms. The outcome of the events was unknown.  Information on the LOT/Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Patient called pharmacy on 10-11-16 to report redness/inflammation at injection site, as well as elevated heart rate. Patient stated these symptoms appeared to resolve after 1 week from time of injection. Patient called pharmacy on 06-26-17 to report that elevated heart rate did not resolve, but continued to persist until a pacemaker was installed in December of 2016. Patient also states that she suffers from muscle weakness and pain, lethargy, and depression. She feels that all of these conditions are an adverse effect of the vaccine.
hospital admission for COVID-19  Narrative: Patient received first Pfizer COVID-19 vaccine on 3/9/21, admitted  to Medical Center on 3/19/21 with severe COVID-19, diagnosed  by positive PCR assay (COVID-19 Fluvid, cycle threshold 19.2), and clinical  syndrome with hypoxia, multifocal pneumonia. Patient required HFNC and was  admitted to MICU for additional care, currently remains in MICU and receiving  dexamethasone, remdesivir, and one dose of tociluzimab.
tightness throat-felt heart was racing BP 137/84, HR98;Bp 122/78, HR 96;
Received the SHINGRIX vaccine on 12/10/2018. On 12/19/18, developed severe vertigo associated with nausea and vomiting. Symptoms also associated with some GI distress, constipation, and urinary frequency and urgency. At about same time developed atrial fibrillation. Have had some degree of vertigo, dizziness, and nausea since that date.
Pt is a 33 year old ( DOB: 1988-04-15 ) female who initiated a e-visit for COVID-19 (Coronavirus) evaluation and screening.     PT states her symptoms started 1-2 days ago.   Her symptoms consist of myalgia, malaise, a cough, facial pain or pressure, nasal congestion, a sore throat, ear pain, a headache, chills, and diarrhea.  PT also feels feverish.   Symptom details    Nasal secretions: The color of her mucus is clear.   Cough:Pt coughs a few times an hour and her cough is not more bothersome at night. Phlegm does not come into her throat when she coughs. She believes her cough is caused by post-nasal drip.    Sore throat: Pt reports having moderate throat pain (4-6 on a 10 point pain scale), does not have exudate on her tonsils, and can swallow liquids. She is not sure if the lymph nodes in her neck are enlarged. A rash has not appeared on the skin since the sore throat started.    Temperature: Her current temperature is 102.7 degrees Fahrenheit. Pt has had a temperature over 100 degrees Fahrenheit for 1-2 days.    Facial pain or pressure: The facial pain or pressure feels worse when bending over or leaning forward.    Headache: She states the headache is moderate (4-6 on a 10 point pain scale).     Pt denies having anosmia, rhinitis, teeth pain, ageusia, vomiting, nausea, and wheezing. She also denies having a sinus infection within the past year, having recent facial or sinus surgery in the past 60 days, and taking antibiotic medication in the past month. She is not experiencing dyspnea.   Precipitating events  Within the past week, PT has not been exposed to someone with strep throat. She has not recently been exposed to someone with influenza. PT has not been in close contact with any high risk individuals.   Pertinent COVID-19 (Coronavirus) information  Pt is not concerned that her symptoms may be COVID-19.   Pt does not work or volunteer as healthcare worker or a first responder.   Pt has not had a close contact with a laboratory-confirmed COVID-19 patient within 14 days of symptom onset.    PT has been tested for COVID-19.
Mother notice reaction a day later area where shots were given area was warm. no redness, pain when touching site induration of vaccine reaction was 5x6cm
SORE ARM; STARTED TO GET WEAK; TIRED FEELING; This spontaneous report received from a consumer concerned a 65 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced sore arm, started to get weak, and tired feeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sore arm, started to get weak, and tired feeling. This report was non-serious. This case, from the same reporter is linked to 20211261150.
typical arm swelling; headache; tiredness; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 17 patients. This is the 16th of the seventeen reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The reporter stated that multiple friends (unspecified) had the regular side effect of soreness in the arm. The patient got the vaccine shot in the village and had the typical arm swelling, headache, and tiredness in Jan2021. The outcome of the events was unknown.  Information on lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018227 same reporter/drug/similar event, different patient
Information has been received from a medical assistant concerning a 7 year old male patient who on 15-JUN-1999 was vaccinated with a dose of varicella virus vaccine live. On approximately 28-DEC-2005, the patient developed chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Patient was seated during Tdap and Hep A vaccine administration.  Approx 5 minutes after administration, patient lost consciousness for less than 1 minute.  Initially patient was held in chair, then lowered to the floor.  Patient was conscious and remained on floor approx 20 minutes.  Patient then remained seated approx 10 more minutes before leaving facility.  Called patient on 7/27/12 to verify patient did not have additional problems.
vertigo; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), NAUSEA (nausea) and VOMITING (vomiting) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Mar-2021, the patient experienced VERTIGO (vertigo), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, VERTIGO (vertigo), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.
Rash and hives daily,  sometimea covering 20% of body,  chest, back, underarms,  groun, legs, hands, arms and feet.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a unknown age male patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On or about 08-MAR-2011, the patient was vaccinated with zoster vaccine live(ZOSTAVAX)(strength, dose, frequency, route, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related condition.  On an unknown date, the patient was treated for shingles. The event caused the patient hospitalization.  As a direct and proximate result of Plaintiff's use of the zoster vaccine live(ZOSTAVAX) vaccine, Plaintiff has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies;diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of event was considered as not recovered. The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
2 DAYS AFTER VX - PT DEVELOPED ITCHY RASH ON UPPER TORSO.  TODAY'S EXAM REVEALS DISSEMINATED ERYTHEMATOUS SCALY PLAQUES ON BOTH BREASTS & SHOULDERS C/W DISSEMINATED VACCINIA.
Noticed that evening of injection "Big, red, welt" 4mm x 4mm in size (redness)
Sever upper back and neck pain at 5pm; Sever upper back and neck pain at 5pm; Shivering uncontrollably; Face very flushed; Woke up with headache.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Dec2021 18:30 (Lot number: FJ8762) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Tree nuts" (unspecified if ongoing), notes: Known allergies: Tree nuts; "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?:Yes. Concomitant medication(s) included: ZITHROMAX.  The following information was reported: HEADACHE (non-serious) with onset 15Dec2021 08:00, outcome "not recovered", described as "Woke up with headache."; CHILLS (non-serious) with onset 15Dec2021 16:00, outcome "not recovered", described as "Shivering uncontrollably"; FLUSHING (non-serious) with onset 15Dec2021 16:00, outcome "not recovered", described as "Face very flushed"; BACK PAIN (non-serious), NECK PAIN (non-serious) all with onset 15Dec2021 17:00, outcome "not recovered" and all described as "Sever upper back and neck pain at 5pm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, back pain, neck pain. Therapeutic measures were not taken as a result of chills, flushing.  Additional Information: Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was reported no. No Prolonged Hospitalization. Prior to vaccination, was the patient diagnosed with COVID-19 was reported as yes. Since the vaccination, has the patient been tested for COVID-19 was reported as yes.   No follow-up attempts are possible. No further information is expected.
dizziness; feeling lousy; flu-like symptoms; Is pretty sick; he has felt ill with muscle aches; nausea; weakness; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Mar2021 (Lot number: EN9581) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Heart Disease", start date: 2002 (ongoing). Concomitant medication(s) included: FLU VACCINE VII, administration date 2021. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EL3249), administration date: 15Feb2021, when the patient was 69 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset Mar2021, outcome "unknown", described as "dizziness"; FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "unknown", described as "feeling lousy"; INFLUENZA LIKE ILLNESS (non-serious) with onset Mar2021, outcome "unknown", described as "flu-like symptoms"; ILLNESS (non-serious) with onset Mar2021, outcome "unknown", described as "Is pretty sick"; MYALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "he has felt ill with muscle aches"; NAUSEA (non-serious) with onset Mar2021, outcome "unknown", described as "nausea"; ASTHENIA (non-serious) with onset Mar2021, outcome "unknown", described as "weakness"; FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "fatigue". The events "dizziness", "feeling lousy", "flu-like symptoms", "is pretty sick", "he has felt ill with muscle aches", "nausea", "weakness" and "fatigue" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient not visited emergency room.   No follow-up attempts are possible. No further information is expected.
Pt states that she woke up at 10pm shaking uncontrollably, patient lost consciousness and woke up with sore muscles.